Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: A novel nano-cell composite for drug delivery

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1702-1711

  Hamidi, Mehrdad ^a,b   Rafiei, Pedram ^a   Azadi, Amir ^a,c   Mohammadi Samani, Soliman ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier erythrocytes; Chitosan; Hydrogel nanoparticles; Hypotonic dialysis; Ionotropic gelation; Sodium valproate

Indexed keywords

NANOCOMPOSITE; NANOPARTICLE; VALPROIC ACID;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; ERYTHROCYTE; HUMAN; HYDROGEL; INFRARED SPECTROSCOPY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 79952212446     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22395     Document Type: Article

References (30)

1. Hamidi M, Tajerzadeh H. 2003. Carrier erythrocytes: An overview. Drug Deliv 10:9-20.
2. Hamidi M, Zarrin A, Foroozesh M, Mohammadi-Samani S. 2007. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Rel 118:145-160.
3. Hamidi M, Zarei N, Zarrin AH, Mohammadi-Samani S. 2007. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery. Int J Pharm 338(1-2):70-78.
4. Hamidi M, Zarrin AH, Foroozesh M, Zarei N, Mohammadi-Samani S. 2007. Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b. Int J Pharm 341(1-2):125-133.
5. Hamidi M, Zarei N, Zarrin A, Mohammadi-Samani S 2007. Preparation and validation of carrier human erythrocytes loaded by bovine serum albumin as a model antigen/protein. Drug Deliv 14(5):295-300.
6. Rossi L, Serafini S, Pierigé F, Antonelli A, Cerasi A, Fraternale A, Chiarantini L, Magnani M. 2005. Erythrocyte-based drug delivery. Expert Opin Drug Deliv 2(2):311-322.
7. Hamidi M, Tajerzadeh H, Dehpour AR, Rouini MR, Ejtemaee-Mehr S. 2001. in vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv 8(4):223-230.
8. Foroozesh M. 2007. Preparation and in vitro characterization of carrier erythrocytes for long-circulating delivery of tramadol. Ph. D. Thesis. Shiraz, Iran: School of Pharmacy, Shiraz University of Medical Sciences.
9. Talwar N, Jain NK. 1992. Erythrocytes as carrier of metronidazole: in vitro characterization. Drug Dev Ind Pharm 18:1799-1812.
10. Ataullakhanov FI, Batasheva TV, Vitvitsky VM, Komarova SV. 1993. Effect of glutaraldehyde treatment on rubomycin and hemoglobin leakage from murine erythrocytes loaded with rubomycin. Biotekhnologiia 2:40-43.
11. Tonetti M, Zocchi E, Guida L, Polvani C, Benatti U, Biassoni P, Romei F, Guglielmi A, Aschele C, Sobrero A. 1992. Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin. Adv Exp Med Biol 326:307-317.
12. Vitvitsky VM. 2002. Erythrocytes as carriers of anthracycline antibiotics in vitro and in vivo. In Erythrocyte engineering for Drug Delivery and Targeting; Magnani M, ed. Texas: Landes Bioscience, pp 99-108.
13. Moghimi SM, Hunter AC, Murray JC. 2001. Long-circulating and target specific nanoparticles: Theory to practice. Pharmacol Rev 53:283-318.
14. Vinogradov SV, Bronich TK, Kabanov AV. 2002. Nanosized cationic hydrogels for drug delivery: Preparation, properties, and interactions with cells. Adv Drug Deliv Rev 54(1):135-147.
15. Hamidi M, Azadi A, Rafiei P. 2008. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60(15):1638-1649.
16. Kato Y, Onishi H, Machida Y. 2003. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 4:303-309.
17. Hirano S, Seino H, Akiyama Y, Nonaka I. 1989. Biocompatibility of chitosan by oral and intravenous administration. Polym Eng Sci 59:897-901.
18. Dodane V, Vilivalam D. 1998. Pharmaceutical applications of chitosan. Pharm Sci Technol Today 16:246-253.
19. Paul W, Sharma C. 2000. Chitosan, a drug carrier for the 21st century. S TP Pharm Sci 10:5-22.
20. Sannan T, Kurita K, Iwakura Y. 1976. Studies on chitin, 2. Effect of deacetylation on solubility. Makromol Chem 177:3589-3600.
21. Genta I, Pavanetto F, Conti B, Giunchedi P, Conte U. 1994. Spray-drying for the preparation of chitosan microspheres. Proc Int Symp Control Release Bioact Mater 21:616-617.
22. Gan Q, Wang T. 2007. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces 59:24-34.
23. Fernandez-Urrusuno R, Cavlo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. 1999. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 16:1576-1581.
24. Pan Y, Li Y, Zhao H, Zheng J, Xu H, Wei G, Hao J, Cui F. 2002. Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139-147.
25. Wu Y, Yang W, Wang Ch, Hu J, Fu Sh. 2005. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 295:235-245.
26. Xu Y, Du Y 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 250:215-226.
27. Sanz S, Lizano C, Luque J, Pinilla M. 1999. in vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by hypotonic dialysis procedure. Life Sci 65:2781-2789.
28. Garin MI, Lopez RM, Sanz S, Pinilla M, Luque J. 1996. Erythrocytes as carriers for recombinant human erythropoietin. Pharm Res 13:869-874.
29. Ebrahim A, Ryan WL. 1996. Encapsulation of ribonucleic acid in human red blood cells for use as a reticulocyte quality control material for flow cytometric analysis. Cytometry 25(2):156-163.
30. Chiarantini L, Johnson J, Deloach JR. 1991. Optimized recirculation survival of mouse carrier erythrocytes. Blood Cells 17(3):607-617.